| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 176 | 425 | 83 | 129 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 176 | 425 | 83 | 129 | | | Operating Expenses | | Research Development | 7,192 | 10,528 | 8,799 | 8,032 | | Selling General and Administrative | 2,424 | 2,346 | 2,359 | 2,635 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,440) | (12,450) | (11,074) | (10,539) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 88 | 187 | 136 | | Earnings Before Interest And Taxes | (9,406) | (12,362) | (10,887) | (10,403) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,406) | (12,362) | (10,887) | (10,403) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,406) | (12,362) | (10,887) | (10,403) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,406) | (12,362) | (10,887) | (10,403) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,406) | ($12,362) | ($10,887) | ($10,403) |
|
0.34% Nasdaq 
0.06%
Income Statement
